Skandinaviska Enskilda Banken (SEB)’s Alexion Pharmaceuticals ALXN Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-182,821	Closed	-$33.6M	–	1126
2021 Q2	$33.6M	Sell	182,821 -104,445	-36%	-$17.9M	0.21%	108
2021 Q1	$43.9M	Sell	287,266 -239,247	-45%	-$37M	0.29%	81
2020 Q4	$82.3M	Buy	526,513 +140,098	+36%	+$18M	0.57%	30
2020 Q3	$44.2M	Buy	386,415 +241,804	+167%	+$26.1M	0.32%	72
2020 Q2	$16.2M	Buy	144,611 +31,182	+27%	+$3.31M	0.13%	146
2020 Q1	$10.2M	Sell	113,429 -12,063	-10%	-$1.18M	0.1%	185
2019 Q4	$13.6M	Buy	125,492 +4,685	+4%	+$501K	0.11%	178
2019 Q3	$11.8M	Sell	120,807 -16,655	-12%	-$1.88M	0.1%	190
2019 Q2	$18M	Buy	137,462 +9,512	+7%	+$1.23M	0.16%	131
2019 Q1	$17.3M	Sell	127,950 -6,805	-5%	-$846K	0.16%	132
2018 Q4	$13.1M	Buy	134,755 +3,408	+3%	+$403K	0.12%	151
2018 Q3	$18.3M	Buy	131,347 +12,004	+10%	+$1.51M	0.14%	135
2018 Q2	$14.8M	Buy	119,343 +9,903	+9%	+$1.16M	0.13%	132
2018 Q1	$12.2M	Sell	109,440 -28,678	-21%	-$3.43M	0.12%	130
2017 Q4	$16.5M	Buy	138,118 +7,778	+6%	+$947K	0.14%	123
2017 Q3	$18.3M	Sell	130,340 -12,631	-9%	-$1.72M	0.17%	116
2017 Q2	$17.4M	Sell	142,971 -10,600	-7%	-$1.23M	0.17%	124
2017 Q1	$18.6M	Buy	+153,571	New	+$19.8M	0.19%	108
2016 Q4	–	Sell	-92,820	Closed	-$11.4M	–	756
2016 Q3	$11.4M	Sell	92,820 -5,200	-5%	-$669K	0.12%	136
2016 Q2	$11.4M	Sell	98,020 -32,200	-25%	-$4.57M	0.13%	125
2016 Q1	$18.1M	Buy	+130,220	New	+$19.1M	0.2%	90

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ALXN Position: Q3 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 182,821 shares — an estimated $33.6M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ALXN in Q1 2016 and held it in 21 quarters. The position peaked at $82.3M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Skandinaviska Enskilda Banken (SEB) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 182,821 Alexion Pharmaceuticals shares in Q3 2021, an estimated $33.6M.
Skandinaviska Enskilda Banken (SEB) first reported a position in Alexion Pharmaceuticals in Q1 2016 and held it in 21 quarters.
Skandinaviska Enskilda Banken (SEB)'s Alexion Pharmaceuticals position peaked at $82.3M in Q4 2020.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2021, filed 10 Nov 2021.